Maria Moore

Study Co-ordinator

Since qualifying as a nurse in 1999 I have worked in a variety of settings including A&E, the LSTM Well Travelled Clinic and more recently at the Oxford Vaccine Group where I was a senior research nurse with particular interest in human challenge studies with typhoid/paratyphoid. Other vaccine trial experience includes Ebola, RSV, Hep B, Meningitis B and, in 2020, the Oxford Covid vaccine.

I moved to LSTM in 2021 and after a brief stint with the Accelerator Research Clinic I moved into my current role coordinating a study looking into the transmission of AMR in Liverpool health and care settings. My overseas experience includes work in Lesotho and in Liberia, both post-war and during the ebola outbreak. I completed the CTCM&H at LSTM in 2003 and in 2019 completed an MPH at the University of Liverpool with a dissertation looking at access to pre-travel healthcare and perceptions of risk in VFR travellers.


Current project is looking at tracking antimicrobial resistance across care settings in Liverpool - TRACS.

Selected publications

  • Jin C, Gibani MM, Moore M, Juel HB, Jones E, Meiring J, Harris V, Gardner J, Nebykova A, Kerridge SA, Hill J, Thomaides-Brears H, Blohmke CJ, Yu LM, Angus B, Pollard AJ. Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella Typhi: a randomised controlled, phase 2b trial. Lancet. 2017 Dec 2;390(10111):2472-2480. doi: 10.1016/S0140-6736(17)32149-9. Epub 2017 Sep 28. PMID: 28965718; PMCID: PMC5720597.